Team Medical Affairs News Contact

Team Medical Affairs News Contact

Back

Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514

August 23, 2017

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Medical Affairs News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2023 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED